Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Aron Goldhirsch

1-50 of 207 results

View this query on the Wikidata Query Service
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

scientific article
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

scientific article published in January 2007
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

scientific article
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

scientific article published on 11 March 2013
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

scientific article published on 25 February 2011
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

scientific article published on July 10, 2014
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

scientific article
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial

scientific article published on 18 July 2013
Adjuvant ovarian suppression in premenopausal breast cancer

scientific article
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

scientific article published on 6 August 2007
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial

scientific article published on 6 March 2012
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

scientific article published on 20 October 2011
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole

scientific article
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

scientific article published on 16 February 2017
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

scientific article
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article published on 29 January 2008
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.

scientific article published on 29 July 2013
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials

scientific article published on 05 May 2008
Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

scientific article published on 7 October 2008
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

scientific article
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers

scientific article
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?

scientific article published in March 2003
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

scientific article
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

article
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

scientific article published in April 2002
Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study

scientific article
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases

scientific article published on 21 November 2013
Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

scientific article
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

scientific article published on 19 January 2016
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.

scientific article published on 8 January 2008
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

scientific article
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.

scientific article
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.

scientific article published on 10 March 2008
Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

scientific article published on 23 October 2013
Cardiac toxicity from systemic cancer therapy: a comprehensive review.

scientific article published on September 2010
Molecular pathways: human leukocyte antigen G (HLA-G).

scientific article published on 29 July 2013
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

scientific article
Breast cancer in the elderly.

scientific article
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

scientific article
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

scientific article published on 12 November 2007
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

scientific article
Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome

scientific article published on 24 October 2012
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

scientific article
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

scientific article published on 23 May 2016
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

scientific article published on 6 December 2009
Invasive lobular breast cancer: subtypes and outcome

scientific article
Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

scientific article
Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.

scientific article
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

scientific article

Paulina is supported by:

About Paulina

Help